IL17A and asthma: In conclusion, androgen, as a novel hormonal therapeutic agent, attenuates the BECs regulated Th17 cells (IL-17) differentiation and expression via MBD2 in Th17 cells predominant neutrophilic severe asthma showing new hope for therapeutic prospects and overcoming therapy-resistant issues of severe asthma.